Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-28 to 2023-03-21
Current total value of award: $26956.93
Description: 4560123932!KRYSTEXXA 8 MG/ML VIALML